The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy

Cytokine

Volumn 56, Issue 2, 2011, Pages 466-470

  Yokoyama, Yoko ^a   Fukunaga, Ken ^a   Ikeuchi, Hiroki ^a   Kamikozuru, Koji ^a   Hida, Nobuyuki ^a   Ohda, Yoshio ^a   Iimuro, Masaki ^a   Yoshida, Koji ^a   Kikuyama, Risa ^a   Kato, Kyouichi ^a   Nagase, Kazuko ^a   Nakamura, Shirou ^a   Miwa, Hiroto ^a   Matsumoto, Takayuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

CD4+CD28 T cells; Colectomy; Immunomodulation; Regulatory T cells; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ CD28 T LYMPHOCYTE; COLON RESECTION; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; REGULATORY T LYMPHOCYTE;

UCA;

CD28 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ANTIGENS, CD28; ANTIGENS, CD4; CELL SEPARATION; COLECTOMY; COLITIS, ULCERATIVE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; T-LYMPHOCYTES, REGULATORY;

EID: 80053335509     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.06.021     Document Type: Article

References (40)

1. Allison M.C., Dhillon A.P., Lewis W.G., Pounder R.E. Inflammatory bowel disease 1998, Mosby, London, p. 9-95.
2. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347:417-419.
3. Kornbluth A., Marion J.F., Salomon P., Janowitz H.D. How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol 1995, 20:280-284.
4. Taffet S.L., Das K.M. Sulphasalazine - adverse effects and desensitization. Dig Dis Sci 1983, 28(9):833-842.
5. Present D.H. How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis 2000, 6(1):48-57.
6. Mizoguchi A., Mizoguchi E. Inflammatory bowel disease, past, present and the future: lessons from animal models. Gastroenterology 2008, 43(1):1-17.
7. + T-cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci 2007, 52:2725-2731.
8. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001, 182:18-32.
9. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6(4):345-352.
10. Fuss I.J. Is the Th1/Th2 paradigm of immune regulation applicable to IBD?. Inflamm Bowel Dis 2008, 14(Suppl. 2):S110-S112.
11. Leonard W.J., Donlon T.A., Lebo R.V., Greene W.C. Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. Science 1985, 228:1547-1549.
12. + regulatory T cells. J Leuk Biol 2006, 80:458-470.
13. Wang L., Pan X.D., Xie Y., Zhang G.B., Jiang M., Zheng L., et al. Altered CD28 and CD95 mRNA expression in peripheral blood mononuclear cells from elderly patients with primary non-small cell lung cancer. Chin Med J 2010, 123:51-56.
14. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996, 97:2027-2037.
15. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-258.
16. Lamprecht P., Moosig F., Csernok E., Seitzer U., Schnabel A., Mueller A., Gross W.L. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001, 56:751-757.
17. null T cells. J Clin Immunol 2004, 24:185-196.
18. + regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 2008, 58(3):801-812.
19. high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
20. Lichiger S., Present D.H., Kornbluth A., Gelernt I., Bauer J., Galler G., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994, 330:1841-1845.
21. +, in patients with ulcerative colitis during active and quiescent disease. Clin Exp Immunol 2009, 156:320-327.
22. High T cells in inflammatory bowel disease. Gastroenterology 2005, 128:1868-1878.
23. Lee J.C., Cevallos A.M., Naeem A., Lennard-Jones J.E., Farthing M.J. Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells. Gut 1999, 44:196-202.
24. + regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007, 13(2):191-199.
25. bright T-cells in human intestinal lamina propria as regulatory cells. J Immunol 2004, 3119-3129.
26. Sitohy B., Hammarstrom S., Danielsson A., Hammarstrom M.L. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol 2007, 151:326-333.
27. Van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., Taams L.S. CD4+CD25+ regulatory T cells in rheumatoid arthritis. Arthritis Rheum 2004, 50(9):2775-2785.
28. + regulatory T cells in patients with rheumatoid arthritis. Jpn J Clin Immunol 2006, 29:37-42.
29. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003, 33:215-223.
30. - T-cells in patients with rheumatoid arthritis. Arthritis Res 2002, 5(4):R210-R213.
31. - T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatol Int 2004, 24:351-354.
32. + T-cells in rheumatoid arthritis. Arthritis Res 2007, 9:R87.
33. Hamzaoui K. Paradoxical high regulatory T cell activity in Behcet's disease. Clin Exp Rheumatol 2007, 25:107-113.
34. - T cells are a major source of interferon-γ and tumor necrosis factor-α in Wegener's granulomatosis. Am J Pathol 2002, 160(5):1717-1724.
35. Moosig F., Csernok E., Wang G., Gross W.L. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998, 114:113-118.
36. + regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol 2003, 171:5012-5017.
37. + T cells. J Immunol 2004, 173:6526-6531.
38. - costimulation-independent T cells in multiple sclerosis. J Clin Invest 2001, 108(8):1185-1194.
39. Deng Y., Jing Y., Campbell A.E., Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004, 172:3437-3446.
40. null T cells in patients with acute coronary syndromes. Circulation 2004, 109:1230-1235.